Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waleed Ghanima

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) networkGuillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
American Journal of Hematology|October 27, 2020
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2021
Detection of upper extremity deep vein thrombosis by magnetic resonance non-contrast thrombus imagingLisette F van Dam, Charlotte E A Dronkers, Gargi Gautam, et al.
British Journal of Haematology|January 8, 2025
MicroRNA-199a-5p may be a diagnostic biomarker of primary ITPLamya Garabet, Anbjørg Rangberg, Anna Maria Eriksson, et al.
American Journal of Hematology|November 10, 2020
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatmentNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) networkGuillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
American Journal of Hematology|October 27, 2020
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2021
Detection of upper extremity deep vein thrombosis by magnetic resonance non-contrast thrombus imagingLisette F van Dam, Charlotte E A Dronkers, Gargi Gautam, et al.
British Journal of Haematology|January 8, 2025
MicroRNA-199a-5p may be a diagnostic biomarker of primary ITPLamya Garabet, Anbjørg Rangberg, Anna Maria Eriksson, et al.
American Journal of Hematology|November 10, 2020
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatmentNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Pageof 21